Inventor

MOREAU MONIQUE

FR10 patents

⚠️ This page may combine multiple inventors who share the name “MOREAU MONIQUE”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PASTEUR MERIEUX SERUMS VACC

3 patents

US6045805AApr 4, 2000

Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent

PASTEUR MERIEUX SERUMS VACC62 citations94

US6007818ADec 28, 1999

Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent

PASTEUR MERIEUX SERUMS VACC35 citations91

US7235242B2Jun 26, 2007

IgA1 protease fragment as carrier peptides

PASTEUR MERIEUX SERUMS VACC2 citations55

AVENTIS PASTEUR S A

3 patents

US6472506B1Oct 29, 2002

Polysaccharide-peptide-conjugates

AVENTIS PASTEUR S A71 citations93

US6596861B1Jul 22, 2003

Method for the reductive amination of polysaccharides

AVENTIS PASTEUR S A38 citations91

US7812006B2Oct 12, 2010

Conjugates obtained by reductive amination of the pneumococcus serotype 5 capsular polysaccharide

AVENTIS PASTEUR S A6 citations55

SANOFI PASTEUR SA

1 patent

US9669052B2Jun 6, 2017

Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6

SANOFI PASTEUR SA1 citations60

MISTRETTA NOËLLE

1 patent

US9132181B2Sep 15, 2015

Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6

MISTRETTA NOËLLE1 citations48

MISTRETTA NOELLE

1 patent

US10137145B2Nov 27, 2018

Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified Neisseria meningitidis strains of immunotype L6

MISTRETTA NOELLE0 citations43

SANOFI PASTEUR

1 patent

US7507718B2Mar 24, 2009

Polymyxin B analogs for LPS detoxification

SANOFI PASTEUR1 citations43